Standout Papers

The diagnosis and management of nonalcoholic fatty liv... 2010 2026 2015 2020 4.9k
  1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2017)
    Naga Chalasani, Zobair M. Younossi et al. Hepatology
  2. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012)
    Naga Chalasani, Zobair M. Younossi et al. Hepatology
  3. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology (2012)
    Naga Chalasani, Zobair M. Younossi et al. Gastroenterology
  4. Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States (2011)
    Michael Charlton, Justin M. Burns et al. Gastroenterology
  5. Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study (2010)
    K.D.S. Watt, Rachel Pedersen et al. American Journal of Transplantation
  6. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation (2017)
    David S. Goldberg, Ivo Ditah et al. Gastroenterology
  7. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial (2017)
    Rohit Loomba, Eric Lawitz et al. Hepatology
  8. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012)
    Naga Chalasani, Zobair M. Younossi et al. The American Journal of Gastroenterology
  9. GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease (2018)
    Rohit Loomba, Zeid Kayali et al. Gastroenterology
  10. Broadly neutralizing antibodies abrogate established hepatitis C virus infection (2014)
    Ype P. de Jong, Marcus Dorner et al. Science Translational Medicine
  11. Liver Transplantation 2023: Status Report, Current and Future Challenges (2023)
    Norah A. Terrault, Claire Francoz et al. Clinical Gastroenterology and Hepatology
  12. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance (2023)
    Alan L. Hutchison, Federica Tavaglione et al. Journal of Hepatology
  13. Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis (2024)
    Mazen Noureddin, Michael Charlton et al. Clinical Gastroenterology and Hepatology

Immediate Impact

2 by Nobel laureates 4 from Science/Nature 262 standout
Sub-graph 1 of 15

Citing Papers

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
2023 Standout
82 intermediate papers

Works of Michael Charlton being referenced

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
and 21 more

Author Peers

Author Last Decade Papers Cites
Michael Charlton 18908 12598 5229 6056 247 24.5k
Linda D. Ferrell 12777 10128 6471 2976 222 21.3k
Kris V. Kowdley 19511 14089 5453 4983 446 28.4k
Oscar W. Cummings 10984 4622 5661 3874 198 19.0k
Richard K. Sterling 15359 13320 4301 2821 315 20.0k
Manal F. Abdelmalek 12684 5599 2303 6079 204 16.1k
Naga Chalasani 25932 13934 6535 9759 485 35.8k
Alastair D. Burt 11893 8321 3121 3744 232 17.9k
Geoffrey C. Farrell 19440 9801 3649 6780 213 25.5k
Emmanuel Tsochatzis 11637 9154 3273 2441 298 15.1k
Stephen H. Caldwell 14013 10002 4144 4130 256 18.4k

All Works

Loading papers...

Rankless by CCL
2026